Article Text
Abstract
There is a concern that as a result of COVID-19 there will be a shortage of ventilators for patients requiring respiratory support. This concern has resulted in significant debate about whether it is appropriate to withdraw ventilation from one patient in order to provide it to another patient who may benefit more. The current advice available to doctors appears to be inconsistent, with some suggesting withdrawal of treatment is more serious than withholding, while others suggest that this distinction should not be made. We argue that there is no ethically relevant difference between withdrawing and withholding treatment and that suggesting otherwise may have problematic consequences. If doctors are discouraged from withdrawing treatment, concern about a future shortage may make them reluctant to provide ventilation to patients who are unlikely to have a successful outcome. This may result in underutilisation of available resources. A national policy is urgently required to provide doctors with guidance about how patients should be prioritised to ensure the maximum benefit is derived from limited resources.
- allocation of healthcare resources
- criminal law
- clinical ethics
- decision-making
- distributive justice
Data availability statement
There are no data in this work.
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Statistics from Altmetric.com
Data availability statement
There are no data in this work.
Footnotes
Twitter @Neonatalethics
Contributors JS and DW conceived of the idea and edited the manuscript. DW drafted the outline. JC drafted the legal section and drafted the ethics section. All authors approved the final version. Each author contributed to the design, research, drafting and revision of this manuscript.
Funding This work was supported by the Wellcome Trust, grant number WT203132 to Julian Savulescu, Dominic Wilkinson, and James Cameron, and grant number WT104848 to Julian Savulescu, and Victorian Government’s Operational Infrastructure Support Program to Julian Savulescu and James Cameron.
Disclaimer The funder had no role in the preparation of this manuscript or the decision to submit for publication.
Competing interests DW was a co-author of the British Medical Association COVID-19: ethical issues document and is a member of the British Medical Association Medical Ethics Committee.
Provenance and peer review Not commissioned; internally peer reviewed.
Other content recommended for you
- P194 Inpatient adjustment of sub-optimal home mechanical ventilation (HMV) – an effective use of resources?
- Limitation of treatment at the end of life: an empirical-ethical analysis regarding the practices of physician members of the German Society for Palliative Medicine
- The impact of regional culture on intensive care end of life decision making: an Israeli perspective from the ETHICUS study
- The decision making process regarding the withdrawal or withholding of potential life-saving treatments in a children's hospital
- Worth living or worth dying? The views of the general public about allowing disabled children to die
- When enough is enough; terminating life-sustaining treatment at the patient's request: a survey of attitudes among Swedish physicians and the general public
- Which factors should be included in triage? An online survey of the attitudes of the UK general public to pandemic triage dilemmas
- End-of-life decision-making for newborns: a 12-year experience in Hong Kong
- Withholding and withdrawing life support in critical care settings: ethical issues concerning consent
- Dilemmas in the medical treatment of patients facing inevitable death